​

Lipocine (LPCN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

LPCN Stock Forecast

Lipocine (LPCN) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $10.00, with a high of $10.00 and a low of $10.00. This represents a 216.46% increase from the last price of $3.16.

$2 $3 $4 $5 $6 $7 $8 $9 $10 High: $10 Avg: $10 Low: $10 Last Closed Price: $3.16

LPCN Stock Rating

Lipocine stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (88.89%), 1 Hold (11.11%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 1 8 Strong Sell Sell Hold Buy Strong Buy

LPCN Price Target Upside V Benchmarks

TypeNameUpside
StockLipocine216.46%
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$10.00
Last Closing Price$3.16$3.16$3.16
Upside/Downside--216.46%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2511---2
May, 25-1---1
Apr, 25-1---1
Mar, 25-1---1
Feb, 25-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 24, 2024Scott HenryIndustrial Alliance Securities$10.00$4.54120.26%216.46%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 24, 2024Alliance Global PartnersBuyinitialise

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.19$-2.15$-3.14-----
Avg Forecast$-2.49$-2.15$-2.99$-0.76$-1.22$-1.15$-0.55$0.10
High Forecast$-1.80$-1.52$-1.25$-0.31$-0.51$-0.48$-0.23$0.16
Low Forecast$-3.18$-2.78$-4.73$-1.20$-1.93$-1.82$-0.87$0.04
Surprise %-92.37%-5.02%-----

Revenue Forecast

$-5M $2M $9M $16M $23M $30M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$16.14M$500.00K$-2.85M$11.20M----
Avg Forecast$3.75M$1.81M$-3.07M$9.06M$3.45M$2.61M$8.20M$18.73M
High Forecast$4.55M$2.21M$-1.69M$10.32M$5.00M$2.61M$8.20M$27.13M
Low Forecast$2.95M$1.40M$-4.44M$7.79M$1.90M$2.61M$8.20M$10.32M
Surprise %330.23%-72.31%-7.05%23.66%----

Net Income Forecast

$-25M $-19M $-13M $-7M $-1M $5M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-634.40K$-10.76M$-16.35M$8.35K----
Avg Forecast$-13.14M$-11.35M$-16.35M$-4.06M$-6.43M$-6.06M$-2.90M$526.97K
High Forecast$-9.50M$-8.03M$-6.56M$-1.66M$-2.68M$-2.52M$-1.21M$834.45K
Low Forecast$-16.77M$-14.67M$-24.95M$-6.30M$-10.18M$-9.60M$-4.59M$219.46K
Surprise %-95.17%-5.19%-0.00%-100.21%----

LPCN Forecast FAQ

Is Lipocine stock a buy?

Lipocine stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Lipocine is a favorable investment for most analysts.

What is Lipocine's price target?

Lipocine's price target, set by 9 Wall Street analysts, averages $10 over the next 12 months. The price target range spans from $10 at the low end to $10 at the high end, suggesting a potential 216.46% change from the previous closing price of $3.16.

How does Lipocine stock forecast compare to its benchmarks?

Lipocine's stock forecast shows a 216.46% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for Lipocine over the past three months?

  • June 2025: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Lipocine’s EPS forecast?

Lipocine's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.22, marking a 0% decrease from the reported $0 in 2024. Estimates for the following years are $-1.15 in 2026, $-0.55 in 2027, and $0.1 in 2028.

What is Lipocine’s revenue forecast?

Lipocine's average annual revenue forecast for its fiscal year ending in December 2025 is $3.45M, reflecting a -69.21% decrease from the reported $11.2M in 2024. The forecast for 2026 is $2.61M, followed by $8.2M for 2027, and $18.73M for 2028.

What is Lipocine’s net income forecast?

Lipocine's net income forecast for the fiscal year ending in December 2025 stands at $-6.429M, representing a -77075.56% decrease from the reported $8.35K in 2024. Projections indicate $-6.06M in 2026, $-2.898M in 2027, and $526.97K in 2028.